Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Non-cash Items (2022 - 2025)

Historic Non-cash Items for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $1.7 million.

  • Coya Therapeutics' Non-cash Items fell 7311.68% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 7311.68%. This contributed to the annual value of $5.4 million for FY2024, which is 111984.55% up from last year.
  • According to the latest figures from Q3 2025, Coya Therapeutics' Non-cash Items is $1.7 million, which was down 7311.68% from $7.1 million recorded in Q2 2025.
  • Coya Therapeutics' 5-year Non-cash Items high stood at $7.1 million for Q2 2025, and its period low was $271098.0 during Q4 2022.
  • Its 4-year average for Non-cash Items is $2.7 million, with a median of $1.5 million in 2025.
  • As far as peak fluctuations go, Coya Therapeutics' Non-cash Items surged by 123060.35% in 2024, and later crashed by 7311.68% in 2025.
  • Coya Therapeutics' Non-cash Items (Quarter) stood at $271098.0 in 2022, then soared by 63.29% to $442679.0 in 2023, then surged by 1119.85% to $5.4 million in 2024, then tumbled by 69.13% to $1.7 million in 2025.
  • Its Non-cash Items stands at $1.7 million for Q3 2025, versus $7.1 million for Q2 2025 and $1.3 million for Q1 2025.